Oxidative stress and neuroAIDS: Triggers, modulators and novel antioxidants

Trends in Neurosciences

Volumn 24, Issue 7, 2001, Pages 411-416

  Mollace, Vincenzo ^a   Nottet, Hans S L M ^b   Clayette, Pascal ^c   Turco, Maria C ^d   Muscoli, Carolina ^a   Salvemini, Daniela ^e   Perno, Carlo F ^f  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e MetaPhore Pharmaceuticals   (United States)

^f UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; ANTIOXIDANT; ANTIRETROVIRUS AGENT; CATALASE; FREE RADICAL; GLUTATHIONE; GLYCOPROTEIN GP 120; INTERLEUKIN 1BETA; NITRIC OXIDE; PEROXYNITRITE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIOXIDANT ACTIVITY; BLOOD BRAIN BARRIER; BRAIN TISSUE; CALCIUM TRANSPORT; CELL DEATH; ENZYME ACTIVITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROGLIA; NERVE CELL LESION; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NITRATION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW;

AIDS DEMENTIA COMPLEX; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; ASTROCYTES; BLOOD-BRAIN BARRIER; CATALASE; CELL DEATH; FREE RADICALS; GENE PRODUCTS, TAT; GLUTATHIONE; HIV INFECTIONS; HUMANS; NEURONS; ORGANOMETALLIC COMPOUNDS; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE;

EID: 0035386540     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-2236(00)01819-1     Document Type: Review

References (58)

1. The brain in AIDS: Central nervous system HIV-1 infection and AIDS dementia complex
2. HIV-1-related central nervous system disease
3. Role of mononuclear phagocytes in the pathogenesis of human immunodeficiency virus infection
4. Seminars in medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome
5. HIV-1-infected mononuclear phagocyte secretory products affect neuronal physiology leading to cellular demise: Relevance for HIV-1 associated dementia
6. The role of oxidative stress in HIV disease
7. The keys of oxidative stress in acquired immune deficiency syndrome apoptosis
8. The role of phagocytes in HIV-related oxidative stress
9. Conserved cysteines of immunodeficiency virus type 1 protease are involved in regulation of polyprotein processing and viral maturation of immature virions
10. Protective effect of novel free-radical scavengers in HIV-related apoptosis of human cultured astroglial cells
11. Oxidative stress during viral infection: A review
12. Highly active antiretroviral treatment in HIV infection: Benefits for neuropsychological function
13. Astrocytes and central nervous system endothelial cells do not express B7-1 (CD80) or B7-2 (CD86) immunoreactivity during experimental autoimmune encephalomyelitis
14. Primary macrophages infected by human immunodeficiency virus trigger CD95-mediated apoptosis of uninfected astrocytes
15. Physiology, pathophysiology and pharmacology
16. Nitric oxide: From discovery to the clinic
17. Cytokine-induced nitric oxide generation by cultured astrocytoma cells involves Ca(++)-calmodulin-independent NO-synthase
18. The effect of nitric oxide on cytokine-induced release of PGE2 by human cultured astroglial cells
19. Release of nitric oxide from astroglial cells: A key mechanism in neuroimmune disorders
20. HIV gp120 glycoprotein stimulates the inducible isoform of no synthase in human cultured astrocytoma cells
21. Human immunodeficiency virus type 1 coat protein neurotoxicity mediated by nitric oxide in primary cortical cultures
22. Cytokines and arachidonic metabolites produced during immunodeficiency virus (HIV)-infected macrophage-astroglial interactions: Implications for the neuropathogenesis of HIV disease
23. Increased oxidative stress brought on by pro-inflammatory cytokines in neurodegenerative processes and the protective role of nitrone-based free radical traps
24. Role of immune-derived diffusible mediators in AIDS-associated neurological disorders
25. Inflammatory cytokines: Putative regulators of neuronal and neuroendocrine function
26. Increased peroxynitrite activity in AIDS dementia complex: Implications for the neuropathogenesis of HIV-1 infection
27. Human immunodeficiency virus-1 infected macrophages induce inducible nitric oxide synthase and nitric oxide (NO) production in astrocytes: Astrocytic NO as possible mediator in acquired immunodeficiency syndrome
28. Apoptosis and necrosis: Two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures
29. Chemokine receptor mRNA expression at the in vitro blood-brain barrier during HIV infection
30. Mechanisms of leukocyte trafficking into the CNS
31. The HIV envelope gp120 in the nervous system: Interactions with nitric oxide, interleukin-1beta and nerve growth factor signalling with pathological implications in vivo and in vitro
32. Involvement of interleukin-1beta in the mechanism of human immunodeficiency virus type 1 (HIV-1) recombinant protein gp120-induced apoptosis in the neocortex of rat
33. Amplification of superoxide anion generation in phagocytic cells by HIV-1 infection
34. Oxidative stress, glutamate, and neurodegenerative disorders
35. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly
36. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase
37. Monocyte infiltration is highly associated with loss of the tight junction protein zonula occludens in HIV-1-associated dementia
38. HIV-1 infection alters monocyte interactions with human microvascular endothelial cells
39. Redox signaling: Nitrosylation and related target interactions of nitric oxide
40. Differential compartmentalization of brain ascorbate and glutathione between neurons and glia
41. Expression of antioxidant enzymes in human inflammatory cells
42. Cerebrospinal fluid S-adenosylmethionine (SAMe) and glutathione concentrations in HIV infection: Effect of parenteral treatment with SAMe
43. Molecular mechanism of decreased glutathione content in human immunodeficiency virus type 1 Tat-transgenic mice
44. Glutathione deficiency is associated with impaired survival in HIV disease
45. The role of glutathione in the neurotoxicity of artemisinin derivatives in vitro(2)
46. Plasma glutathione and glutathione disulfide in the rat: Regulation and response to oxidative stress
47. Molecular mechanisms of tumor necrosis factor alpha gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and -independent pathways
48. HIV-1-induced neuronal injury in the developing brain
49. Platelet-activating factor receptor activation. An initiator step in HIV-1 neuropathogenesis
50. Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: Protection by the antioxidant N-acetylcysteine and the genes bcl-2 and crmA
51. Redox status of cells influences constitutive or induced NF-kappa B translocation and HIV long terminal repeat activity in human T and monocytic cell lines
52. Oxidative stress and nuclear factor-kappaB activation: A reassessment of the evidence in the light of recent discoveries
53. Suppression of intracellular hydrogen peroxide generation and catalase levels in CD8+ T-lymphocytes from HIV+ individuals
54. Postischemic, systemic administration of polyamine-modified superoxide dismutase reduces hippocampal CA1 neurodegeneration in rat global cerebral ischemia
55. Metalloporphyrin class of therapeutic catalytic antioxidants
56. Protective effects of a superoxide dismutase mimetic and peroxynitrite decomposition catalysts in endotoxin-induced intestinal damage
57. A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats
58. The protective effect of M40401 superoxide dismutase mimetic in post-ischemic brain damage in rats